TMPyP4 tosylate
(Synonyms: TMPYP[=Α,Β,Γ,Δ-四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐][铜和镁用超高灵敏分光光度试剂][用于以高效液相色谱金属同时测定],TMP 1363) 目录号 : GC12092
TMPyP4 tosylate是一种四链体特异性配体,可以抑制G-四链体与胰岛素样生长因子I(IGF-1)之间的相互作用。
Cas No.:36951-72-1
Sample solution is provided at 25 µL, 10mM.
TMPyP4 tosylate is a quadruplex-specific ligand that can inhibit the interaction between G-quadruplexes and Insulin-like growth factor type I (IGF-1)[1].
In vitro, TMPyP4 tosylate (50 or 100µM; 96h) significantly inhibited telomerase activity in telomerase positive HOS and Saos-2 cells, induced telomere shortening, and inhibited the cell growth in HOS and Saos-2 cells with over 17% apoptosis rates[2]. At a fixed irradiation fluence of 2.4J/cm², the photosensitization effect of TMPyP4 tosylate (10µM; 30min) resulted in more than three logs greater killing of C. albicans than methylene blue (MB) at the same incubation concentration[3].
In vivo, After applying an ethanol/glycerol/water formulation of TMPyP4 tosylate (0.3mg/mL; 30min) to the mouse ear, photodynamic therapy (PDT) was performed., the CFU count of Candida albicans in the infected ear was significantly reduced by approximately 50-fold compared to the untreated control group[3]. In the Lewis lung carcinoma model, mice treated with TMPyP4 tosylate (25µg/g/twice a week; 4 weeks; i.p.) exhibited significant inhibition of both primary tumor progression and lung metastasis development[4].
References:
[1] Chen H, Sun H, Chai Y, et al. Insulin-like growth factor type I selectively binds to G-quadruplex structures. Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):31-38.
[2] Fujimori J, Matsuo T, Shimose S, et al. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. J Orthop Res. 2011 Nov;29(11):1707-11.
[3] Mitra S, Haidaris CG, Snell SB, et al. Effective photosensitization and selectivity in vivo of Candida Albicans by meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate. Lasers Surg Med. 2011 Apr;43(4):324-32.
[4] Aviezer D, Cotton S, David M, et al. Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis. Cancer Res. 2000 Jun 1;60(11):2973-80.
TMPyP4 tosylate是一种四链体特异性配体,可以抑制G-四链体与胰岛素样生长因子I(IGF-1)之间的相互作用[1]。
体外实验中,TMPyP4 tosylate(50或100µM; 96小时)显著抑制了端粒酶阳性HOS和Saos-2细胞中的端粒酶活性,诱导端粒缩短,并抑制了HOS和Saos-2细胞的生长,使细胞凋亡率超过17%[2]。在固定的光照射强度为2.4J/cm²的条件下,TMPyP4 tosylate(10µM; 30分钟)的光敏化效果对白色念珠菌的杀伤作用比相同浓度下亚甲蓝(MB)的效果高出三个数量级以上[3]。
体内实验中,使用乙醇/甘油/水配方的TMPyP4 tosylate(0.3mg/mL; 30分钟)涂抹在小鼠耳部进行光动力疗法(PDT)后,感染耳部的白色念珠菌的菌落形成单位(CFU)计数比未处理的对照组显著减少了约50倍[3]。在Lewis肺癌模型中,接受TMPyP4 tosylate(25µg/g/每周两次; 4周; 腹腔注射)治疗的小鼠表现出对原发肿瘤进展和肺转移发展的显著抑制作用[4]。
Cell experiment [1]: | |
Cell lines |
The human osteosarcoma cell lines HOS, Saos-2, MG-63, and U2OS cells |
Preparation Method |
Telomerase Assay |
Reaction Conditions |
50 or 100µM; 96h |
Applications |
TMPyP4 tosylate significantly inhibited telomerase activity in telomerase positive HOS and Saos-2 cells, induced telomere shortening, and inhibited the cell growth in HOS and Saos-2 cells with over 17% apoptosis rates. |
Animal experiment [2]: | |
Animal models |
female BALB/c mice |
Preparation Method |
Establishment of Infection Model |
Dosage form |
0.3mg/mL; 30min |
Applications |
After photodynamic therapy (PDT) with TMPyP4 tosylate using an ethanol/glycerol/water formulation, the CFU count of Candida albicans in the infected ear was significantly reduced by approximately 50-fold compared to the untreated control group. |
References: |
Cas No. | 36951-72-1 | SDF | |
别名 | TMPYP[=Α,Β,Γ,Δ-四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐][铜和镁用超高灵敏分光光度试剂][用于以高效液相色谱金属同时测定],TMP 1363 | ||
分子式 | C72H66N8O12S4 | 分子量 | 1363.6 |
溶解度 | 15 mg/mL in DMSO (Need ultrasonic); 5 mg/mL in Water (ultrasonic and warming and heat to 60°C) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 0.7334 mL | 3.6668 mL | 7.3335 mL |
5 mM | 0.1467 mL | 0.7334 mL | 1.4667 mL |
10 mM | 0.0733 mL | 0.3667 mL | 0.7334 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet